Barbarić Jelena, Coebergh Jan Willem, Šekerija Mario
Mario Šekerija, MD, PhD Croatian National Cancer Registry Croatian Institute of Public Health Rockefellerova 7 University of Zagreb, School of Medicine Andrija Štampar School of Public Health Department of Medical Statistics, Epidemiology and Medical Informatics Rockefellerova 4, 10000 Zagreb, Croatia;
Acta Dermatovenerol Croat. 2017 Dec;25(4):285-291.
Mortality rates and five-year relative survival for malignant melanoma (MM) of the skin in Croatia are poor compared with most European countries. Epidemiological data recorded at the National Cancer Registry (CNCR) are used for informing various decision-makers and researchers, as well as for comparisons with other countries. We analyzed CNCR data on MM skin and morphology for 2000-2007 and 2008-2014 and compared them with European 2000-2007 data. We further stratified skin site analyses in Croatia by sex, different age groups, and sources of reports. We found 52% of case with "non-specified sites" in Croatia in 2000-2007; however, that proportion decreased to 36% in 2008-2014, with 29% of registered MM cases occurring on the trunk, 22% on the limbs, and 13% on the head and neck. The proportion of "non-specified sites" cases in reports originating from university hospitals decreased by 25% and by 9.2% in those from general hospitals. The proportion of "not otherwise specified" among histologically verified cases decreased from 96% in 2000-2007 to 84% in 2008-2014. Our results reveal a substantial proportion of inadequately reported cases, in particular when compared to data at the European level, where in 2000-2007 only 7.7% of cases were from "non-specified sites" and 19% were of non-specified morphology. Irrespective of recent progress, the proportion of unspecified cases still hampers insight into site distribution by subgroups. A further increase in the overall completeness of MM data within CNCR is needed to enable research-informed improvement of melanoma control in the country. Our findings call for engagement of all stakeholders in optimization of the national melanoma registration processes and using models such as RegisTree
与大多数欧洲国家相比,克罗地亚皮肤恶性黑色素瘤(MM)的死亡率和五年相对生存率较低。国家癌症登记处(CNCR)记录的流行病学数据用于为各类决策者和研究人员提供信息,以及与其他国家进行比较。我们分析了CNCR在2000 - 2007年和2008 - 2014年期间关于MM皮肤和形态的数据,并将其与欧洲2000 - 2007年的数据进行比较。我们还按性别、不同年龄组和报告来源对克罗地亚的皮肤部位分析进行了分层。我们发现,2000 - 2007年克罗地亚有52%的病例“部位未明确”;然而,这一比例在2008 - 2014年降至36%,其中29%的注册MM病例发生在躯干,22%在四肢,13%在头颈部。来自大学医院报告中的“部位未明确”病例比例下降了25%,来自综合医院的下降了9.2%。组织学确诊病例中“未另行说明”的比例从2000 - 2007年的96%降至2008 - 2014年的84%。我们的结果显示,有相当一部分病例报告不充分,特别是与欧洲层面的数据相比,在2000 - 2007年欧洲只有7.7%的病例来自“部位未明确”,19%的病例形态未明确。尽管最近有所进展,但未明确病例的比例仍然妨碍了对亚组部位分布的深入了解。需要进一步提高CNCR内MM数据的整体完整性,以便在该国基于研究改进黑色素瘤控制。我们的研究结果呼吁所有利益相关者参与优化国家黑色素瘤登记流程,并使用RegisTree等模型